SEC Form 4 · accession 0001225208-15-022513
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Young
Officer — Group President
Period of report
Dec 14, 2015
Accepted (ET)
Dec 16, 2015 · 6:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2015 | M | 31,500 | $26.20 | A | 163,999 | D | |
| Common StockF1 | Dec 14, 2015 | F | 28,765 | $31.93 | D | 135,234 | D | |
| Common Stock | holding | — | — | — | 1,120 | I | By Rule 16b-3 Plan | |
| Common Stock | holding | — | — | — | 1,331 | I | By Trustee under the Pfizer Share Ownership Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $26.20 | Dec 14, 2015 | M | 31,500 | D | — | Feb 22, 2016 | Common Stock | 31,500 | 0 | D |
| Phantom Stock Units SSPF3,F4 | — | Dec 15, 2015 | A | 6 | A | — | — | Common Stock | 6 | 5,125 | D |
Explanation of responses
- F1The reported transaction constitutes the withholding of shares which were retained by the Issuer to satisfy the payment of the exercise price and tax obligations in connection with an exercise of stock options through a net settlement.
- F2These options are fully exercisable.
- F3Each unit represents one phantom share of common stock.
- F4These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.